AI assistant
AVATION PLC — Director's Dealing 2019
Aug 23, 2019
4886_dirs_2019-08-23_76a6fc69-9177-4de2-93d9-8e33d805b3c7.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1121K
Avast PLC
23 August 2019
Avast plc
(the "Company")
23 August 2019
Director/PDMR Shareholding
The below individual sold 974,728 ordinary shares of 10 pence each in the Company (the "Ordinary Shares") at a price of £ 3.6720 per Ordinary Share and a total sale price of £3,579,220.71.
The Notification of Dealing Form provided in accordance with the requirements of the Market Abuse Regulation in relation to this transaction is set out below:
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
ERWIN GUNST
2
Reason for the notification
a)
Position/status
NON EXECUTIVE DIRECTOR
b)
Initial notification /Amendment
INITIAL NOTIFICATION
3
Details of the issuer
a)
Name
Avast plc
b)
LEI
213800IR8G8LC2H4BO27
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
ORDINARY SHARES OF GBP 0.10 EACH IN AVAST PLC (ISIN: GB00BDD85M81)
b)
Nature of the transaction
SALE OF SHARES
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| GBP 3.6720 | 974,728 |
d)
Aggregated information
- Aggregated volume - Price
| Aggregated volume: 974,728 ORDINARY SHARES |
| Aggregated price: GBP 3,579,220.71 |
e)
Date of the transaction
21 August 2019
f)
Place of the transaction
LONDON STOCK EXCHANGE (XLON)
Alan Rassaby
Company Secretary
Avast Plc.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHXXLFLKVFXBBB